Menu

• Ask a Health Expert about BONE MARROW TRANSPLANT
• Post Your Side Effect related to BONE MARROW TRANSPLANT
• BONE MARROW TRANSPLANT and FDA Warnings
• BONE MARROW TRANSPLANT in Patients Wiki
• Report BONE MARROW TRANSPLANT in Drug Side Effect Survey

BONE MARROW TRANSPLANT side effect

What is BONE MARROW TRANSPLANT ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Clolar Side Effects Report #5619800-5
Physician from UNITED STATES reported CLOLAR problem on Nov 30, 2007. Male patient, child 12 years of age, weighting 69.23 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, klebsiella infection, pancytopenia, pneumonia, sepsis, sinusitis fungal, . CLOLAR dosage: 40 MG/M2 DAILY IV. During the same period patient was treated with PREDNISONE, ZOFRAN, PENTAMIDINE ISETHIONATE, NIFEDIPINE, FLUCONAZOLE, MAGNESIUM, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 11/12/2007.

Cyclophosphamide Side Effects Report #5625537-9
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Male patient, weighting 166.7 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, fluid overload, leukaemia recurrent, renal failure acute, respiratory distress, sepsis, . CYCLOPHOSPHAMIDE dosage: 9000 MG. During the same period patient was treated with METHOTREXATE, RAPAMYCIN, TACROLIMUS, THIOTEPA. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5592346-9
Physician from JAPAN reported PROGRAF problem on Dec 26, 2007. Female patient, 17 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, venoocclusive liver disease, . PROGRAF dosage: unknown. During the same period patient was treated with BUSULFEX, METHOTREXATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5592456-6
VELCADE problem was reported by a Physician from ITALY on Jan 02, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, disease progression, mass, motor dysfunction, neurological symptom, sensory loss, . VELCADE dosage: unknown. Patient recovered.


Busulfan Side Effects Report #5608392-2
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Jan 11, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, haemorrhage, herpes virus infection, liver disorder, myelodysplastic syndrome, pneumonia, respiratory depression, stomatitis, . BUSULFAN dosage: 27.68 ML;X1;IV. During the same period patient was treated with VALPROATE, FLUDARABINE PHOSPHATE. Patient died on 07/26/2007.

Velcade Side Effects Report #5572378-7
VELCADE problem was reported by a Physician from SPAIN on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, . VELCADE dosage: 1.30 MG/M2,. Patient died.

Velcade Side Effects Report #5572380-5
Physician from SPAIN reported VELCADE problem on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, complications of bone marrow transplant, . VELCADE dosage: 1.30 MG/M2,. Patient died.

Velcade Side Effects Report #5573210-8
VELCADE problem was reported by a Physician from SPAIN on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, . VELCADE dosage: 1.30 MG /M2. Patient died.

Isotretinoin Side Effects Report #5476718-9
Physician from UNITED STATES reported ISOTRETINOIN problem on Sept 17, 2007. Male patient, child 1 years of age, was treated with ISOTRETINOIN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, . ISOTRETINOIN dosage: 30 MG, ORAL. Patient recovered.


Busulfan Side Effects Report #5503594-8
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2007. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, candida sepsis, cardiogenic shock, pneumonia, staphylococcal sepsis, stomatitis, . BUSULFAN dosage: 26 ML;QD;IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient recovered.

Methotrexate Side Effects Report #5504474-4
Consumer or non-health professional from ISRAEL reported METHOTREXATE problem on Oct 16, 2007. Male patient, 52 years of age, was diagnosed with b precursor type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, chronic graft versus host disease, hepatotoxicity, jaundice cholestatic, leukaemia, no therapeutic response, . METHOTREXATE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, VINCRISTINE, DAUNORUBICIN, ASPARAGINASE, CYTARABINE. Patient recovered.

Busulfan Side Effects Report #5468658-6
BUSULFAN problem was reported by a Health Professional from JAPAN on Sept 11, 2007. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, oedema, staphylococcal sepsis, . BUSULFAN dosage: 24.6 ML; QD; IV; 32.8 ML;QD;IV; 8.2 ML;QD;IV. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.

Antineoplastic Side Effects Report #5469119-0
Physician from FRANCE reported ANTINEOPLASTIC AGENTS problem on Sept 12, 2007. Male patient, 27 years of age, was diagnosed with bone marrow transplant and was treated with ANTINEOPLASTIC AGENTS. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, capillary leak syndrome, graft versus host disease, . ANTINEOPLASTIC AGENTS dosage: unknown. During the same period patient was treated with GLEEVEC. Patient recovered.

Revlimid Side Effects Report #5430354-9
REVLIMID problem was reported by a Physician from UNITED STATES on Aug 22, 2007. Male patient, 66 years of age, weighting 160.0 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, . REVLIMID dosage: 25 MG, QD, ORAL. Patient died on 08/20/2007.


Aldurazyme Side Effects Report #5390720-7
Physician from CANADA reported ALDURAZYME problem on Nov 07, 2006. Male patient, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, cardiac valve disease, condition aggravated, deafness, hydrocephalus, kyphoscoliosis, . ALDURAZYME dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390724-4
ALDURAZYME problem was reported by a Physician from NETHERLANDS on Mar 24, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, transplant failure, . ALDURAZYME dosage: unknown. Patient died.

Aldurazyme Side Effects Report #5390728-1
Physician from CANADA reported ALDURAZYME problem on Jan 23, 2006. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, haemolytic anaemia, . ALDURAZYME dosage: 1 MG/KG QWK IV. Patient died on 03/09/2005.

Prograf Side Effects Report #5401427-1
PROGRAF problem was reported by a Health Professional from COLOMBIA on July 13, 2007. Female patient, 42 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, infection, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with OMEPRAZOLE, FOLIC ACID. Patient died on 06/27/2007.

Aldurazyme Side Effects Report #5390720-7
Physician from CANADA reported ALDURAZYME problem on Nov 07, 2006. Male patient, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, cardiac valve disease, condition aggravated, deafness, hydrocephalus, kyphoscoliosis, . ALDURAZYME dosage: unknown. Patient was hospitalized. Patient recovered.


Aldurazyme Side Effects Report #5390724-4
ALDURAZYME problem was reported by a Physician from NETHERLANDS on Mar 24, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, transplant failure, . ALDURAZYME dosage: unknown. Patient died.

Aldurazyme Side Effects Report #5390728-1
Physician from CANADA reported ALDURAZYME problem on Jan 23, 2006. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, haemolytic anaemia, . ALDURAZYME dosage: 1 MG/KG QWK IV. Patient died on 03/09/2005.

Prograf Side Effects Report #5401427-1
PROGRAF problem was reported by a Health Professional from COLOMBIA on July 13, 2007. Female patient, 42 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, infection, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with OMEPRAZOLE, FOLIC ACID. Patient died on 06/27/2007.

Tasigna Side Effects Report #5765713-8
Health Professional from UNITED STATES reported TASIGNA problem on June 03, 2008. Male patient was diagnosed with chronic myeloid leukaemia and was treated with TASIGNA. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, electrocardiogram qt prolonged, platelet count decreased, rash, . TASIGNA dosage: 400 MG, QAM, 200 MG QPM. Patient recovered.

Busulfex Side Effects Report #5729834-8
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, dermatitis, diarrhoea, febrile neutropenia, infection, mucosal inflammation, . BUSULFEX dosage: 6 ML INTRAVENOUS; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, CLONAZEPAM, LENOGRASTIM, NARTOGRASTIM, METHOTREXATE. Patient recovered.

Busulfex Side Effects Report #5698111-6
Consumer or non-health professional from JAPAN reported BUSULFEX problem on Mar 21, 2008. Female patient, 63 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, hepatic function abnormal, renal impairment, . BUSULFEX dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with TACROLIMUS. Patient recovered.

Busulfex Side Effects Report #5698113-X
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 30 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, pseudomonal sepsis, . BUSULFEX dosage: unknown. Patient recovered.

Busulfex Side Effects Report #5698126-8
Consumer or non-health professional from JAPAN reported BUSULFEX problem on Mar 21, 2008. Male patient, 25 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, bone marrow transplant rejection, perianal abscess, pneumonia staphylococcal, staphylococcal pharyngitis, stomatitis, surgical procedure repeated, . BUSULFEX dosage: unknown. Patient died.

Busulfex Side Effects Report #5698179-7
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 15 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, haematuria, proteinuria, . BUSULFEX dosage: unknown. During the same period patient was treated with NEUPOGEN. Patient recovered.

Busulfex Side Effects Report #5698188-8
Consumer or non-health professional from JAPAN reported BUSULFEX problem on Mar 21, 2008. Female patient, 29 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, bronchopulmonary aspergillosis, serratia sepsis, stomatitis, venoocclusive liver disease, . BUSULFEX dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, LENOGRATIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.

Ambisome Side Effects Report #5345802-2
AMBISOME problem was reported by a Health Professional from JAPAN on May 21, 2007. Female patient, 14 years of age, was diagnosed with pneumonia fungal and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, hypokalaemia, inflammation, pulmonary haemorrhage, . AMBISOME dosage: unknown. During the same period patient was treated with PROGRAF, VANCOMYCIN HYDROCHLORIDE. Patient died on 03/30/2007.

Ambisome Side Effects Report #5376568-8
Consumer or non-health professional from JAPAN reported AMBISOME problem on May 21, 2007. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, deafness, . AMBISOME dosage: 100 MG, IV DRIP. Patient recovered.

Revlimid Side Effects Report #5335538-6
REVLIMID problem was reported by a Physician from UNITED STATES on May 15, 2007. Male patient, 57 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, graft versus host disease, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/09/2007.

Revlimid Side Effects Report #5285432-4
Physician from UNITED STATES reported REVLIMID problem on Mar 23, 2007. Female patient, 43 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, disease progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/13/2007.

Busulfan Side Effects Report #5663691-3
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Feb 22, 2008. Female patient, 16 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant, malaise, nausea, nystagmus, staphylococcal sepsis, stomatitis, vertigo, vomiting, . BUSULFAN dosage: 20 ML;QD;IV. During the same period patient was treated with PHENYTOIN, CYCLOPHOSPHAMIDE, FILGRASTIM, METHOTREXATE, TRACOLIMUS. Patient was hospitalized. Patient recovered.

Lupron Side Effects Report #5679166-1
Consumer or non-health professional from CANADA reported LUPRON DEPOT problem on Mar 17, 2008. Female patient, 39 years of age, was treated with LUPRON DEPOT. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, bone marrow transplant, pallor, pancytopenia, . LUPRON DEPOT dosage: 3.75 MG, ONCE, INTRAMUSCULAR. During the same period patient was treated with MINOCIN, PREDNISONE. Patient recovered.

Thalomid Side Effects Report #5625325-3
THALOMID problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 35 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, bone marrow transplant, . THALOMID dosage: 200 MG, 1 IN 1 D,ORAL; 200 MG,4 IN 1 D, ORAL; 200 MG,DAILY, ORAL. Patient recovered.

Prograf Side Effects Report #5592426-8
Physician from JAPAN reported PROGRAF problem on Dec 26, 2007. Female patient, child 12 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, bone marrow transplant, dermatitis atopic, eosinophilic pustular folliculitis, pruritus, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.

Thalomid Side Effects Report #5592778-9
THALOMID problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient, 35 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, bone marrow transplant, . THALOMID dosage: 200 MG, 1 IN 1 D, ORAL; 200 MG, 4 IN 1 D, ORAL. Patient recovered.

Thalomid Side Effects Report #5602435-8
Physician from UNITED STATES reported THALOMID problem on Jan 16, 2008. Female patient, 35 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, bone marrow transplant, . THALOMID dosage: 200 MG, 1 IN 1 D, ORAL. Patient recovered.

Busulfan Side Effects Report #5564610-0
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 03, 2007. Male patient, 13 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant, malaise, nausea, sepsis, stomatitis, . BUSULFAN dosage: 24.8 ML; QD; IV. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5572379-9
Physician from SPAIN reported VELCADE problem on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, bone marrow transplant, disease progression, . VELCADE dosage: 1.30 MG/M2,. Patient died.

Novantrone Side Effects Report #5533773-5
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bone marrow transplant, hepatosplenomegaly, pancytopenia, polycystic liver disease, . NOVANTRONE dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.

Immunoglobulins Side Effects Report #5480107-0
Consumer or non-health professional from FRANCE reported IMMUNOGLOBULINS problem on Oct 04, 2007. Male patient, 18 years of age, was diagnosed with erythropenia and was treated with IMMUNOGLOBULINS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, bone marrow transplant, dyspnoea, haemolysis, hypertension, hypoxia, klebsiella infection, lung disorder, . IMMUNOGLOBULINS dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, RAPAMUNE, ARANESP, CORTANCYL, TRIATEC, ORACILLINE, ZELITREX, MAGNE B. Patient was hospitalized. Patient died.

Busulfan Side Effects Report #5496979-X
BUSULFAN problem was reported by a Health Professional from JAPAN on Oct 09, 2007. Male patient, child .8 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, bone marrow transplant, cholecystitis, diarrhoea, hypoalbuminaemia, oral intake reduced, platelet count decreased, sepsis, . BUSULFAN dosage: 0.45 ML; X1; IV, 5.08 ML; X1; IV. Patient was hospitalized. Patient recovered.

Busulfan Side Effects Report #5496980-6
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Oct 09, 2007. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant, diarrhoea, enterococcal sepsis, nausea, pathogen resistance, respiratory failure, staphylococcal sepsis, stomatitis, . BUSULFAN dosage: 26.8 ML; X1; IV. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized and became disabled. Patient died on 08/11/2007.

Carboplatin Side Effects Report #5501526-X
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 11, 2007. Female patient, child 9 years of age, was diagnosed with retinoblastoma bilateral and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bone marrow transplant, . CARBOPLATIN dosage: (80 MG, 4 / CYCLICAL) SUNCONJUNCTIVAL, (1160 MG, 4 / CYCLICAL). During the same period patient was treated with CYCLOSPORINE, TENIPOSIDE, VINCRISTINE. Patient recovered.

Procrit Side Effects Report #5463368-3
Consumer or non-health professional from UNITED STATES reported PROCRIT problem on Sept 10, 2007. Female patient, 58 years of age, weighting 145.1 lb, was diagnosed with myelodysplastic syndrome and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: arthralgia, bone marrow transplant, gait disturbance, . PROCRIT dosage: unknown. Patient was hospitalized. Patient recovered.

Elspar Side Effects Report #5764172-9
ELSPAR problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2008. Female patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia recurrent, bone marrow transplant, chronic graft versus host disease, no therapeutic response, post procedural complication, pulmonary veno-occlusive disease, stomatitis, . ELSPAR dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, METHOTREXATE, DAUNOMYCIN, CYCLOPHOSPHAMIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Elspar Side Effects Report #5765220-2
Consumer or non-health professional from UNITED STATES reported ELSPAR problem on May 23, 2008. Male patient, 24 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia recurrent, bone marrow transplant, cardiomegaly, dyspnoea exertional, oedema peripheral, productive cough, pulmonary hypertension, venoocclusive disease, venous pressure jugular increased, . ELSPAR dosage: unknown. During the same period patient was treated with DACTINOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, ARABINOSYLCYTOSINE, VINCRISTINE SULPHATE, PREDNISONE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Busulfex Side Effects Report #5769154-9
BUSULFEX problem was reported by a Physician from JAPAN on May 29, 2008. Female patient, 62 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant, cytomegalovirus infection, enterocolitis viral, graft versus host disease, pneumonia, stomatitis, . BUSULFEX dosage: 28 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Busulfex Side Effects Report #5782929-5
Consumer or non-health professional from JAPAN reported BUSULFEX problem on June 11, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant, malaise, nausea, sepsis, vomiting, . BUSULFEX dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN. Patient died on 07/19/2006.